Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Russell, Nicola"'
Autor:
Voorwerk L; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Slagter M; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Horlings HM; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Sikorska K; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van de Vijver KK; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Pathology, Ghent University Hospital, Ghent, Belgium., de Maaker M; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Nederlof I; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Kluin RJC; Genomics Core Facility, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Warren S; NanoString Technologies, Inc, Seattle, WA, USA., Ong S; NanoString Technologies, Inc, Seattle, WA, USA., Wiersma TG; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Russell NS; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Lalezari F; Department of Radiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Schouten PC; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Bakker NAM; Oncode Institute, Utrecht, the Netherlands.; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Ketelaars SLC; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Peters D; Core Facility Molecular Pathology & Biobanking, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Lange CAH; Department of Radiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Werkhoven E; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Tinteren H; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Mandjes IAM; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Kemper I; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Onderwater S; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Chalabi M; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Gastrointestinal Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Wilgenhof S; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Haanen JBAG; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Salgado R; Department of Pathology, GZA-ZNA Ziekenhuizen, Antwerp, Belgium.; Division of Research, Peter Mac Callum Cancer Center, Melbourne, Victoria, Australia., de Visser KE; Oncode Institute, Utrecht, the Netherlands.; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Sonke GS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Wessels LFA; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Linn SC; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Schumacher TN; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Blank CU; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Kok M; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. m.kok@nki.nl.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. m.kok@nki.nl.
Publikováno v:
Nature medicine [Nat Med] 2019 Jul; Vol. 25 (7), pp. 1175.
Autor:
Voorwerk L; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Slagter M; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Horlings HM; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Sikorska K; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van de Vijver KK; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Pathology, Ghent University Hospital, Ghent, Belgium., de Maaker M; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Nederlof I; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Kluin RJC; Genomics Core Facility, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Warren S; NanoString Technologies, Inc., Seattle, WA, USA., Ong S; NanoString Technologies, Inc., Seattle, WA, USA., Wiersma TG; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Russell NS; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Lalezari F; Department of Radiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Schouten PC; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Bakker NAM; Oncode Institute, Utrecht, the Netherlands.; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Ketelaars SLC; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Peters D; Core Facility Molecular Pathology & Biobanking, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Lange CAH; Department of Radiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Werkhoven E; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Tinteren H; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Mandjes IAM; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Kemper I; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Onderwater S; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Chalabi M; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Gastrointestinal Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Wilgenhof S; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Haanen JBAG; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Salgado R; Department of Pathology, GZA-ZNA Ziekenhuizen, Antwerp, Belgium.; Division of Research, Peter Mac Callum Cancer Center, Melbourne, Victoria, Australia., de Visser KE; Oncode Institute, Utrecht, the Netherlands.; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Sonke GS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Wessels LFA; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Linn SC; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Schumacher TN; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Blank CU; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Kok M; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. m.kok@nki.nl.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. m.kok@nki.nl.
Publikováno v:
Nature medicine [Nat Med] 2019 Jun; Vol. 25 (6), pp. 920-928. Date of Electronic Publication: 2019 May 13.